Literature DB >> 18551131

Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.

M Kvansakul1, H Yang, W D Fairlie, P E Czabotar, S F Fischer, M A Perugini, D C S Huang, P M Colman.   

Abstract

Apoptosis is an important part of the host's defense mechanism for eliminating invading pathogens. Some viruses express proteins homologous in sequence and function to mammalian pro-survival Bcl-2 proteins. Anti-apoptotic F1L expressed by vaccinia virus is essential for survival of infected cells, but it bears no discernable sequence homology to proteins other than its immediate orthologues in related pox viruses. Here we report that the crystal structure of F1L reveals a Bcl-2-like fold with an unusual N-terminal extension. The protein forms a novel domain-swapped dimer in which the alpha1 helix is the exchanged domain. Binding studies reveal an atypical BH3-binding profile, with sub-micromolar affinity only for the BH3 peptide of pro-apoptotic Bim and low micromolar affinity for the BH3 peptides of Bak and Bax. This binding interaction is sensitive to F1L mutations within the predicted canonical BH3-binding groove, suggesting parallels between how vaccinia virus F1L and myxoma virus M11L bind BH3 domains. Structural comparison of F1L with other Bcl-2 family members reveals a novel sequence signature that redefines the BH4 domain as a structural motif present in both pro- and anti-apoptotic Bcl-2 members, including viral Bcl-2-like proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551131     DOI: 10.1038/cdd.2008.83

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  96 in total

1.  Structural changes in the BH3 domain of SOUL protein upon interaction with the anti-apoptotic protein Bcl-xL.

Authors:  Emmanuele Ambrosi; Stefano Capaldi; Michele Bovi; Gianmaria Saccomani; Massimiliano Perduca; Hugo L Monaco
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

2.  The vaccinia virus-encoded Bcl-2 homologues do not act as direct Bax inhibitors.

Authors:  Antonio Postigo; Michael Way
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

3.  Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention.

Authors:  Anton V Cheltsov; Mika Aoyagi; Alexander Aleshin; Eric Chi-Wang Yu; Taylor Gilliland; Dayong Zhai; Andrey A Bobkov; John C Reed; Robert C Liddington; Ruben Abagyan
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

4.  Bax forms an oligomer via separate, yet interdependent, surfaces.

Authors:  Zhi Zhang; Weijia Zhu; Suzanne M Lapolla; Yiwei Miao; Yuanlong Shao; Mina Falcone; Doug Boreham; Nicole McFarlane; Jingzhen Ding; Arthur E Johnson; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

5.  Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers.

Authors:  Kyoung Joon Oh; Pawan Singh; Kyungro Lee; Kelly Foss; Shinyoub Lee; Minji Park; Steffi Lee; Sreevidya Aluvila; Matthew Park; Puja Singh; Ryung-Suk Kim; Jindrich Symersky; D Eric Walters
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

6.  Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif.

Authors:  Jingzhen Ding; Zhi Zhang; G Jane Roberts; Mina Falcone; Yiwei Miao; Yuanlong Shao; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

7.  XIAP impairs mitochondrial function during apoptosis by regulating the Bcl-2 family in renal cell carcinoma.

Authors:  Chao Chen; Tian Shu Liu; Si Cong Zhao; Wen Zheng Yang; Zong Ping Chen; Yong Yan
Journal:  Exp Ther Med       Date:  2018-03-20       Impact factor: 2.447

Review 8.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

9.  tBid undergoes multiple conformational changes at the membrane required for Bax activation.

Authors:  Aisha Shamas-Din; Scott Bindner; Weijia Zhu; Yehudit Zaltsman; Clinton Campbell; Atan Gross; Brian Leber; David W Andrews; Cécile Fradin
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

Review 10.  Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis.

Authors:  D Westphal; R M Kluck; G Dewson
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.